This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jul. 25, 2012

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  


Genetic weak spots may help shape new colon cancer treatments
The New York Times via Omaha World-Herald    Share    Share on FacebookTwitterShare on LinkedinE-mail article
More than 200 researchers investigating colon cancer tumors have found genetic vulnerabilities that could lead to powerful new treatments. The hope is that medications designed to strike weak spots will eventually stop a cancer that is now almost inevitably fatal once it has spread. Scientists increasingly see cancer as a genetic disease defined not so much by where it starts — colon, liver, brain, breast — but by genetic aberrations that are its Achilles' heel. More

Congratulations to our 2012 cytotechnology graduates!
ASCT    Share    Share on FacebookTwitterShare on LinkedinE-mail article
ASCT wishes you the best in your new profession. Remember to make use of the ASCT Career Center, a free service that provides access to cytotechnology jobs and employers. In addition to posting resumes, job seekers can browse and view available positions based on their criteria and save those jobs for later review if they choose. Job seekers can also create a search agent which will send email notifications of jobs that match their criteria. You can access the Career Center from the tab at the top bar of all ASCT Viewpoints.

Employers can use the Career Center to post positions online, search for qualified candidates based on specific job criteria, and create an online resume agent to email qualified candidates daily. They also benefit from online reporting that provides job activity statistics.

As a registered employer or job seeker ASCT's Career Center also provides you with access to the National Healthcare Career Network (NHCN), a network of over 60 top healthcare associations and professional organizations. ASCT's alliance with NHCN increases your reach to over 7,000 resumes and over 1,500 job postings — giving you more control over your career advancement and a one-stop-shop to find quality candidates.

ASCT also offers resume and interviewing tips in the Student Forum section of the ASCT website. Good luck!


Event       Location     Dates Notes

The Cytology Association
of Alabama
      Birmingham, Ala.    July 28 More details

ASCT Educational Webinar:
New Cervical Cancer Screening Guidelines: What do they mean for me?
      Your PC    July 31, 2 p.m. EST Ann T. Moriarty M.D., Co-Chairman,
Work Group 6 Looking to the Future - Potential Impact of Molecular Screening
More details | Register

California Association of Cytotechnologists
Annual Seminar/Workshop
      Crowne Plaza,
      Irvine, Calif.
   Sept. 15 For more information contact Matt Riding at

Pathology Update 2012
“New Roles for Pathologists in the Era of Health Care Reform”
      University of
      Allen Health Care,
      Burlington, Vt.
   Sept. 22 For more information, contact Lisa Kapoor at

SOP: An Important Form of Laboratory Communication       Your PC    Sept. TBA
   2 p.m. EST
Debora A. Smith, CT (ASCP)
Cytology Supervisor, The Methodist Hospital, Houston, Texas
More details | Register

The ASCT 2012-2013 membership year has started! Renew your membership Here.

HPV improves survival for African-Americans with throat cancer
Science Codex    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Even though the human papillomavirus is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African-Americans with throat cancer, say Henry Ford Hospital researchers. According to their new study, HPV has a substantial impact on overall survival in African Americans with oropharyngeal cancer, a cancer that affects part of the throat, the base of the tongue, the tonsils, the soft palate and the walls of the pharynx. More

Report focuses on sustainability of infectious disease surveillance
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Just as the globalization of trade and travel is rapidly evolving, so is the globalization of infectious diseases and the need for cooperative approaches to detect, prevent and control them, according to Dr. David Dausey, chair of the Mercyhurst University Public Health Department. The outbreaks of Severe Acute Respiratory Syndrome and avian influenza H5N1 in recent years showed how infectious diseases can significantly impact national economies and exposed the need for cooperation in detecting and controlling disease to protect populations and economies. More


Researchers discover switch that lets early lung cancer grow unchecked
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cellular change thought to happen only in late-stage cancers to help tumors spread also occurs in early-stage lung cancer as a way to bypass growth controls, say researchers at the Mayo Clinic in Florida. The finding, reported in Science Translational Medicine, represents a new understanding of the extent of transformation that lung cancer — and likely many other tumor types — undergo early in disease development, the scientists say. More

Unique 'double hit' medication results in potential leukemia treatment
Medical Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new drug using a "double hit" approach to stop cancer from developing shows potential in leukemia treatment. The drug works by targeting the FLT3 gene. About 30 percent of acute myeloid leukemia patients have a fault in that particular gene that makes the cancer harder to treat. The drug stops cells from proliferating. In healthy blood cells, the gene FLT3 signals the cells to grow while another protein called Aurora kinase helps in cell division. More

FDA approves new medication for HIV prevention study
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new federally funded study will look at the use of another type of HIV drug in healthy people with the aim of preventing them from becoming infected with virus that causes AIDS, the National Institutes of Health recently said. The announcement follows the approval by the Food and Drug Administration of Gilead Sciences Inc.'s Truvada for use in healthy people considered at high risk of becoming infected with HIV, such as those who have an HIV-infected partner. More

Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almost all of them will eventually become resistant. Now, researchers at the University of Michigan Comprehensive Cancer Center have discovered one reason why the cancer cells become resistant: They turn on a completely different pathway, one that is involved in inflammation, fueling the cancer independently of HER2. More


The new science behind America's deadliest diseases
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
What do heart disease, diabetes, Alzheimer's, stroke and cancer have in common? Scientists have linked each of these to a condition known as chronic inflammation, and they are studying how high-fat foods and excess body weight may increase the risk for fatal disorders. Inflammation is the body's natural response to injury and outside irritants. But when the irritants don't let up, because of a diet of high-fat foods, too much body fat and smoking, for example, the immune system can spiral out of control and increase the risk for disease. More

Belgian scientists develop way to detect 'superparasites'
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists at the Institute of Tropical Medicine in Antwerp, Belgium, made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani, they identified a series of mutations specific of "superparasites" and developed a simple assay that should allow tracking them anywhere. More

Oregon man recovering from bubonic plague
Reuters via NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An Oregon man who contracted a rare case of bubonic plague, a disease that ravaged Europe during the Middle Ages, is expected to lose his fingers and some toes, but should be well enough to leave the hospital within weeks, his family recently said. Paul Gaylord, 59, spent almost a month in intensive care after he was infected while trying to take a rodent from the mouth of his cat. More


ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
July 25, 2012
July 11, 2012
June 27, 2012
June 18, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063